Cuban authorities have approved the first vaccine for use to increase the lives of patients with lung cancer and the vaccine is available in Cuban hospitals, told Cuban scientist on Tuesday.

The drug named Cima Vax EGF has shown good results to raise survival rates of four to five months and even longer in some patients on average basis, the scientists stated in a new conference at Cuba’s Center of Molecular Immunology.
Contrary to chemotherapy, Cima Vax EGF has fewer side effects because it contains modified proteins that target only the cancer cells.

The scientists told that there were other vaccines currently being tested in other parts of the world but CimaVax EGF was the first lung cancer approved vaccine anywhere in the world.
…Click here to read more

Nicotine Addiction in the Perils of Fatalism

An inherited alternative has been enormously acknowledged just in recent times. It leads the chain smoking people extra elastic towards their trend of addiction along with nicotine’s. The use of much expandable smoking raised a lot of risk factors among the people as the scientists and the laboratory physician of Pathology in a minute ago diagnosed. The continuous use of smoking will lead the smokers at marginal level of the lungs cancer. This crucial research is done by the National Institute on Drug Abuse as well as given by the National Institute of Health.

The chief executive of NIH Dr. Elias Zerhouni demonstrated a most occurring prediction. The all researches and studies will soon press forward the chances of hereditary investigations. This will more classify all the DNA discrepancies. Which will in future enhance the threat of complicated bio deeds muddles?

…Click here to read more

‘Aspirin’ can be an effective medication for the women as an inexpensive lung cancer chemoprevention though causing few side effects. A recent research study findings give a clear indication with clinical evidences.

This specific case-control study involved almost 581 African-American and Caucasian women with and without’ non-small-cell lung cancer (NSCLC)’. Findings of the study revealed that the regular use of aspirin helps in reducing the risk for the disease by a significant 34% rate among women.

Certain previous specific research studies also indicated that aspirin and other similar ‘non-steroidal anti-inflammatory drugs (NSAIDs)’ have potential for decreasing the risk for NSCLC. Some of the other studies however, established that the results of this degree are not quite possible.

…Click here to read more